🔗 Permalink

Inventor profile of:

Mark WILLIAMS

City:

Lawrence, Kansas

Country:

United States

Published Applications:

Last publication date:

2025-11-27

Top Assignees for applications by Mark WILLIAMS

The entities that hold a legal rights for patent applications filed by inventor WILLIAMS Mark:

CRITITECH, INC. 5 Lawrence, KS United States

Recent patent applications by WILLIAMS Mark

Mark WILLIAMS from Lawrence, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-11-27

US20250360166A1

Human necessities

Cisplatin particles and uses thereof

#2 | 2024-07-11

US20240226116A1

Human necessities

Glucocorticoid Particles and Their Use

#3 | 2024-07-04

US20240216424A1

Human necessities

CISPLATIN PARTICLES AND USES THEREOF

#4 | 2024-05-16

US20240156861A1

Human necessities

Cisplatin particles and uses thereof

#5 | 2023-12-28

US20230414510A1

Human necessities

NICLOSAMIDE PARTICLES AND USES THEREOF

#6 | 2023-11-16

US20230364021A1

Human necessities

Sorafenib particles and uses thereof

#7 | 2023-05-11

US20230142591A1

Human necessities

Niraparib particles and uses thereof

#8 | 2023-05-11

US20230142186A1

Human necessities

Rucaparib particles and uses thereof

#9 | 2022-11-24

US20220370355A1

Human necessities

Lapatinib particles and uses thereof

#10 | 2022-08-04

US20220241257A1

Human necessities

Sorafenib particles and uses thereof

#11 | 2022-01-27

US20220023215A1

Human necessities

Lapatinib particles and uses thereof

#12 | 2021-12-16

US20210387961A1

Chemistry; metallurgy

CIPROFLOXACIN POLYMORPH AND ITS USE

#13 | 2020-08-06

US20200247780A1

Chemistry; metallurgy

Ciprofloxacin polymorph and its use

#14 | 2020-08-06

US20200246355A1

Human necessities

Glucocorticoid “nintedanib” particles and their use

InventorID:

2811668 ⎘